合計 48 件の最近のインサイダー取引記録が記録されています BeOne Medicines Ltd. (ONC), 内訳は 14 件の買い および 31 件の売り. インサイダー買い総額は $20.15M インサイダー売り総額は $21.34M.
最近活動のある主要インサイダーには Lee Chan Henry, Oyler John, Wu Xiaobin. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ONC
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-11 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
341 |
$300.00 |
$102.3K |
- |
| 2026-03-06 |
Oyler John |
Chief Executive Officer |
RSU 付与（制限付株式） |
326,976 |
- |
- |
5,491,339 |
| 2026-03-06 |
Wu Xiaobin |
President and COO |
RSU 付与（制限付株式） |
168,922 |
- |
- |
1,137,900 |
| 2026-03-06 |
Wang Lai |
President, Global Head of R&d |
RSU 付与（制限付株式） |
112,606 |
- |
- |
1,564,030 |
| 2026-03-06 |
Lee Chan Henry |
SVP, General Counsel |
RSU 付与（制限付株式） |
65,390 |
- |
- |
288,496 |
| 2026-03-06 |
Rosenberg Aaron |
Chief Financial Officer |
RSU 付与（制限付株式） |
79,014 |
- |
- |
294,346 |
| 2026-02-04 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
996 |
$350.00 |
$348.6K |
- |
| 2026-01-07 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
664 |
$331.76 |
$220.29K |
- |
| 2025-12-31 |
Wang Lai |
President, Global Head of R&d |
RSU 付与（制限付株式） |
427,895 |
- |
- |
1,451,424 |
| 2025-12-16 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
40 |
$305.24 |
$12.21K |
- |
| 2025-12-15 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
1,194 |
$314.92 |
$376.01K |
24,369 |
| 2025-12-11 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
332 |
$325.00 |
$107.9K |
- |
| 2025-12-10 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
332 |
$318.28 |
$105.67K |
- |
| 2025-11-26 |
Sanders Corazon (corsee) D. |
Director |
情報に基づく売り |
804 |
$342.47 |
$275.35K |
- |
| 2025-11-17 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
10 |
$382.32 |
$3.82K |
- |
| 2025-11-13 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
1,769 |
$381.05 |
$674.08K |
- |
| 2025-11-12 |
Oyler John |
Chief Executive Officer |
贈与（送付） |
858,533 |
- |
- |
6,441,041 |
| 2025-11-12 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
154 |
$362.07 |
$55.76K |
6,009 |
| 2025-11-12 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
332 |
$350.00 |
$116.2K |
- |
| 2025-11-11 |
Oyler John |
Chief Executive Officer |
贈与（送付） |
151,320 |
- |
- |
7,299,574 |
| 2025-11-07 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
贈与（送付） |
424,073 |
- |
- |
4,582,601 |
| 2025-10-08 |
Lee Chan Henry |
SVP, General Counsel |
オプション行使 |
296 |
$159.03 |
$47.07K |
9,559 |
| 2025-06-24 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
情報に基づく売り |
100 |
$267.81 |
$26.78K |
- |
| 2025-06-23 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
100 |
$262.90 |
$26.29K |
- |
| 2025-06-23 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
1,363 |
$260.00 |
$354.38K |
- |
| 2025-06-23 |
Wang Lai |
Global Head of R&d |
情報に基づく売り |
1,028 |
$260.00 |
$267.28K |
- |
| 2025-06-17 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
1,460 |
$256.49 |
$374.47K |
- |
| 2025-06-17 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
630 |
$250.87 |
$158.05K |
- |
| 2025-06-17 |
Wang Lai |
Global Head of R&d |
情報に基づく売り |
470 |
$251.37 |
$118.14K |
- |
| 2025-06-16 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
3,680 |
$266.05 |
$979.05K |
1,460 |
| 2025-06-16 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
100 |
$266.22 |
$26.62K |
630 |
| 2025-06-16 |
Wang Lai |
Global Head of R&d |
情報に基づく売り |
1,177 |
$266.40 |
$313.56K |
470 |
| 2025-06-16 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
422 |
$266.50 |
$112.46K |
- |
| 2025-06-11 |
Ball Titus B. |
Principal Accounting Officer |
情報に基づく売り |
134 |
$258.36 |
$34.62K |
- |
| 2025-06-10 |
Oyler John |
Chief Executive Officer |
RSU 付与（制限付株式） |
348,374 |
$20.26 |
$7.06M |
348,374 |
| 2025-06-10 |
Yi Qingqing |
Director |
その他（売り） |
29,614 |
- |
- |
27,326 |
| 2025-06-10 |
Wang Xiaodong |
Other: Chair, Scientific Advisory Brd |
情報に基づく売り |
100 |
$264.85 |
$26.49K |
- |
| 2025-06-10 |
Ball Titus B. |
Principal Accounting Officer |
RSU 付与（制限付株式） |
29,601 |
- |
- |
73,983 |
| 2025-06-10 |
Wu Xiaobin |
President and COO |
RSU 付与（制限付株式） |
232,245 |
$20.26 |
$4.71M |
232,245 |
| 2025-06-10 |
Wang Lai |
Global Head of R&d |
RSU 付与（制限付株式） |
162,565 |
$20.26 |
$3.29M |
162,565 |
| 2025-06-10 |
Lee Chan Henry |
SVP, General Counsel |
RSU 付与（制限付株式） |
88,244 |
$20.26 |
$1.79M |
88,244 |
| 2025-06-10 |
Rosenberg Aaron |
Chief Financial Officer |
RSU 付与（制限付株式） |
119,873 |
$20.26 |
$2.43M |
119,873 |
| 2025-06-06 |
Oyler John |
Chief Executive Officer |
情報に基づく売り |
400 |
$255.74 |
$102.3K |
- |
| 2025-06-06 |
Wu Xiaobin |
President and COO |
情報に基づく売り |
234 |
$255.77 |
$59.85K |
- |
| 2025-06-06 |
Wang Lai |
Global Head of R&d |
情報に基づく売り |
300 |
$255.30 |
$76.59K |
- |
| 2025-06-06 |
Lee Chan Henry |
SVP, General Counsel |
情報に基づく売り |
230 |
$256.79 |
$59.06K |
- |
| 2025-05-21 |
Baker Bros. Advisors Lp |
Director |
RSU 付与（制限付株式） |
45,500 |
$18.19 |
$827.65K |
45,500 |
| 2025-02-28 |
Baker Bros. Advisors Lp |
Director |
情報に基づく売り |
60,851 |
$260.00 |
$15.82M |
730,642 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
